(FNX) First Trust Mid Cap Core - Ratings and Ratios

Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US33735B1089

Mid-Cap, Stocks, ETF, Returns, Alpha

Description: FNX First Trust Mid Cap Core

The First Trust Mid Cap Core AlphaDEX® Fund (FNX) is an actively managed ETF that seeks to outperform traditional mid-cap indices by investing in a portfolio of stocks selected using the AlphaDEX methodology. This approach aims to identify securities with potential for positive alpha, or risk-adjusted returns, from the NASDAQ US600 Mid Cap Index.

The AlphaDEX selection process is a rules-based system that evaluates stocks based on various fundamental and quantitative factors, aiming to create a portfolio with a higher potential for returns relative to its risk. By focusing on mid-cap stocks, FNX targets a segment of the market that is often characterized by a balance between growth potential and relative stability.

As of the latest data, FNX has demonstrated a certain level of price momentum, with its last price at $112.84, above its 20-day Simple Moving Average (SMA) of $111.88 and significantly above its 50-day SMA of $107.58. However, it is below its 200-day SMA of $114.18, indicating a potential resistance level. The Average True Range (ATR) of 1.47, or 1.30%, suggests moderate volatility.

Given the current technical indicators and fundamental data, including an Assets Under Management (AUM) of $1.12 billion, a forecast for FNX could involve a potential breakout if it surpasses the 200-day SMA and maintains momentum. Conversely, failure to break through this resistance could lead to a pullback towards the 50-day SMA. Investors should monitor the ATR for signs of increasing volatility, which could signal a significant move in either direction.

To capitalize on potential opportunities, investors could consider FNX as part of a diversified portfolio, especially if they are bullish on the mid-cap segment and believe in the effectiveness of the AlphaDEX selection methodology. However, its crucial to continuously evaluate the funds performance relative to its index and peers, as well as broader market conditions, to make informed investment decisions.

Additional Sources for FNX ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

FNX ETF Overview

Market Cap in USD 1,108m
Category Mid-Cap Blend
TER 0.60%
IPO / Inception 2007-05-08

FNX ETF Ratings

Growth Rating 54.2
Fundamental -
Dividend Rating 52.5
Rel. Strength -5.96
Analysts -
Fair Price Momentum 106.97 USD
Fair Price DCF -

FNX Dividends

Dividend Yield 12m 1.05%
Yield on Cost 5y 2.05%
Annual Growth 5y 11.08%
Payout Consistency 97.5%
Payout Ratio %

FNX Growth Ratios

Growth Correlation 3m 83%
Growth Correlation 12m -15.2%
Growth Correlation 5y 73.6%
CAGR 5y 14.40%
CAGR/Max DD 5y 0.58
Sharpe Ratio 12m 0.05
Alpha -7.43
Beta 0.969
Volatility 17.31%
Current Volume 9.9k
Average Volume 20d 10.4k
What is the price of FNX shares?
As of July 02, 2025, the stock is trading at USD 114.85 with a total of 9,861 shares traded.
Over the past week, the price has changed by +1.69%, over one month by +4.03%, over three months by +5.64% and over the past year by +8.25%.
Is First Trust Mid Cap Core a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, First Trust Mid Cap Core (NASDAQ:FNX) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 54.17 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FNX is around 106.97 USD . This means that FNX is currently overvalued and has a potential downside of -6.86%.
Is FNX a buy, sell or hold?
First Trust Mid Cap Core has no consensus analysts rating.
What are the forecasts for FNX share price target?
According to our own proprietary Forecast Model, FNX First Trust Mid Cap Core will be worth about 125.6 in July 2026. The stock is currently trading at 114.85. This means that the stock has a potential upside of +9.35%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 125.6 9.4%